Kiromic BioPharma Reports 32% Decrease in Tumor Volume Eight Months Post-Treatment in Fourth Patient Enrolled in Deltacel-01
Kiromic BioPharma, Inc. (OTCQB: KRBP) ("Kiromic" or the "Company") reports favorable ongoing efficacy results from the ...
HUTCHMED’s Lung Cancer Therapy Gains Breakthrough Status
Limited (HK:0013) has released an update.Pick the best stocks and maximize your portfolio:Discover top-rated stocks from ...
News Medical10h
PROSPECT-Lung trial aims to improve treatment for patients with resectable non-small cell lung cancer
The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...
A Montana hospital let a beloved doctor continue to practice despite concerns
Hailed as a savior, Dr. Thomas C. Weiner became a patient favorite and his hospital’s highest earner. As the myth surrounding him grew, so did the trail of patient harm.
Study reveals increase in late-stage breast cancer diagnoses in US
The number of women with late-stage, invasive breast cancer at the time of diagnosis increased significantly among U.S. women ...
Hosted on MSN1d
AZN, Daiichi's ADC Gets FDA Breakthrough Tag for EGFR-Mutated NSCLC
AstraZeneca AZN and its Japanese partner Daiichi Sankyo announced that the FDA has granted a Breakthrough Therapy designation ...
Immutep Announces Initiation of TACTI-004 Phase III Trial in First Line Non-Small Cell Lung Cancer
The receipt of regulatory approval from the Australian Therapeutic Goods Administration to commence the TACTI-004 trial is a significant milestone for Immutep and marks its transformation into a Phase ...
Business Wire2d
Zetagen Therapeutics Shares In-vivo Dose Optimization Data of ZetaMAST™ (Zeta-MBC-005) Metastatic Breast Cancer in Liver
About Zetagen Therapeutics Founded in 2015, Zetagen Therapeutics is a private, clinical-stage, biopharmaceutical company ...
Managed Healthcare Executive2d
Next-Generation Testing Cheaper and More Effective for Guiding Lung Cancer Treatment
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...
WebMD2d
FDA Approves Drug for Aggressive Small-Cell Lung Cancer
The FDA has approved the drug durvalumab for adults with limited-stage small-cell lung cancer (LS-SCLC) whose disease hasn’t gotten worse after getting platinum-based chemo and radiation at the same ...
Incyte reports positive Phase 3 data for Zynyz for lung cancer
Incyte (INCY) reported positive results from a Phase 3 study of its drug Zynyz in the treatment of non-small cell lung cancer ...
Science Daily2d
In five cancer types, prevention and screening have been major contributors to saving lives
Improvements in cancer prevention and screening have averted more deaths from five cancer types combined over the past 45 years than treatment advances, according to a modeling study. The study looked ...